Alere Inc (ALR) 41.60 $ALR Noteworthy Wednesday Option

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2016 at 10:04 PM

Alere Inc (ALR) 41.60 $ALR

Noteworthy Wednesday Option Activity: ALR, UNT, FORM
DividendChannel.com - Wed Jun 22, 2:28PM CDT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alere Inc. , where a total of 15,553 contracts have traded so far, representing approximately 1.6 million underlying shares.
ALR: 41.60 (-0.98)

GPM Reminds Investors of the June 20 Deadline in the Class Action Lawsuit Against Alere Inc.
BusinessWire - Mon Jun 20, 11:39AM CDT
Glancy Prongay & Murray LLP ("GPM"

reminds investors of the June 20, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class"

of investors who purchased Alere Inc. ("Alere" or the "Company"

(NYSE: ALR) securities between May 9, 2013 and April 20, 2016, inclusive (the "Class Period"

. Alere investors have until June 20, 2016 to file a lead plaintiff motion.
ALR: 41.60 (-0.98)

3-Day Deadline Alert: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Alere Inc. And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jun 17, 6:01PM CDT
IRVINE, CA / ACCESSWIRE / June 17, 2016 / Khang & Khang LLP (the "Firm"

announces that a class action lawsuit has been filed against Alere Inc. ("Alere" or the "Company"

(NYSE: ALR). Investors who purchased or otherwise acquired shares between May 9, 2013 and April 20, 2016, inclusive (the "Class Period"

, are encouraged to contact the Firm prior to the June 20, 2016, lead plaintiff motion deadline.
ALR: 41.60 (-0.98)

DEADLINE ALERT, Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Alere, Inc. (ALR) and Lead Plaintiff Deadline: June 20, 2016
ACCESSWIRE - Fri Jun 17, 9:23AM CDT
NEW YORK, NY / ACCESSWIRE / June 17, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors of class action against Alere, Inc. ("Alere" or "the Company"

(NYSE: ALR). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Alere, Inc. securities during the period between May 9, 2013 and April 20, 2016 inclusive (the "Class Period"

.
ALR: 41.60 (-0.98)

INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Alere Inc. and a Lead Plaintiff Deadline of June 20, 2016 - ALR
GlobeNewswire - Tue Jun 14, 10:27AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Alere Inc. (NYSE:ALR) securities between May 9, 2013 and April 20, 2016.
ALR: 41.60 (-0.98)

JUNE 20 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit Against Alere Inc. And Advises Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jun 10, 7:48PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 10, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Alere Inc. ("Alere" or the "Company"

(NYSE: ALR) and certain of its officers. The class action, filed in United States District Court, District of Massachusetts, and docketed under 16-cv-10834, is on behalf of a class consisting of all persons or entities who purchased Alere securities between May 9, 2013 and April 20, 2016 inclusive (the "Class Period"

. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act"

.
ALR: 41.60 (-0.98)

Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Alere Inc. (NYSE: ALR) Securities Case
GlobeNewswire - Fri Jun 10, 10:45AM CDT
Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"

, a global investor rights law firm, reminds investors that June 20, 2016 is the last day to file lead plaintiff papers in the securities lawsuit against Alere Inc. ("Alere" or "Company"

(NYSE:ALR) and certain of its directors (collectively, "Defendants"

. Alere investors are encouraged to go to: http://www.scott-scott.com/cases/new/securiti...c-alr.html. You can also contact Joseph Halloran at (646) 582-0121 or e-mail jhalloran@scott-scott.com for information.
ALR: 41.60 (-0.98)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alere Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of June 20, 2016 - ALR
GlobeNewswire - Fri Jun 10, 9:32AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ALR: 41.60 (-0.98)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Alere, Inc. (ALR) and Lead Plaintiff Deadline: June 20, 2016
ACCESSWIRE - Thu Jun 09, 9:01AM CDT
NEW YORK, NY / ACCESSWIRE / June 9, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Alere, Inc. ("Alere" or "the Company"

.
ALR: 41.60 (-0.98)

SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Alere Inc. and Advises Investors with Losses to Contact the Firm
BusinessWire - Tue Jun 07, 12:56PM CDT
Lundin Law PC announces a class action lawsuit has been filed against Alere Inc. ("Alere" or the "Company"

(NYSE: ALR) concerning possible violations of federal securities laws between May 9, 2013 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the June 20, 2016, lead plaintiff motion deadline.
ALR: 41.60 (-0.98)

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Alere Inc. Of Upcoming Deadline
GlobeNewswire - Mon Jun 06, 3:20PM CDT
Rigrodsky & Long, P.A.:
ALR: 41.60 (-0.98)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alere Inc. of Commencement of Class Action Lawsuit and a Lead Plaintiff Deadline of June 20, 2016
BusinessWire - Mon Jun 06, 12:28PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ALR: 41.60 (-0.98)

Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
PR Newswire - Thu Jun 02, 3:30PM CDT
Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR. . The dividend is payable on July 15, 2016 to holders of record of Series B stock at the close of business on July 1, 2016.
ALR: 41.60 (-0.98)

June 20 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Alere Inc.
BusinessWire - Wed Jun 01, 11:07AM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming June 20, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class"

of investors who purchased Alere Inc. ("Alere" or the "Company"

(NYSE: ALR) securities between May 9, 2013 and April 20, 2016, inclusive (the "Class Period"

. Alere investors have until June 20, 2016 to file a lead plaintiff motion.
ALR: 41.60 (-0.98)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Alere Inc. and a Lead Plaintiff Deadline of June 20, 2016
BusinessWire - Wed Jun 01, 10:22AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Alere Inc. (NYSE: ALR) securities between May 9, 2013 and April 20, 2016.
ALR: 41.60 (-0.98)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Tennessee's Bold Lung Cancer Trial Signals Innovation

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Miranda Lambert Lights Up Red Kettle Campaign

By Logan Wright Updated Oct 25, 2026 Category News Views 227

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...